Status:
WITHDRAWN
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Lead Sponsor:
University of Rochester
Conditions:
Crohn's Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine the best role for capsule endoscopy in diagnosing Crohn's disease.
Detailed Description
Wireless capsule endoscopy (CE) is a Food and Drug Administration (FDA) approved technology that allows viewing of the entire small-bowel. Capsule endoscopy involves swallowing a pill-sized camera tha...
Eligibility Criteria
Inclusion
- English speaking adult patients (\>18 years old) with known Crohn's disease
Exclusion
- Severe medical or psychiatric co-morbidities
- Active swallowing problems
- Bowel obstruction
- History of stricture or fistula
- Pregnancy
- Taking aspirin/non-steroidal anti-inflammatory drug (NSAID) or potassium chloride (KCl) within 4 weeks prior to the colonoscopy and anytime after colonoscopy
- Inability to consent
- Exclusion of patients whose colonoscopy was done for reasons other than signs/symptoms suggestive of Crohn's disease
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00178438
Start Date
June 1 2005
End Date
June 1 2006
Last Update
September 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642